Drugs / Buprenorphine/Naloxone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00270257 | May 2008 → Jul 2012 | HIV infectious disease, opiate dependence | National Institute of Allergy and Infectious Diseases (NIAID) | Terminated | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Buprenorphine/Naloxone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00270257 ↗ |
| Route | Oral | “Oral tablet” NCT00270257 ↗ |